Search Results - Pamela K. Allen
- Showing 1 - 20 results of 43
- Go to Next Page
-
1
-
2
Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer by Arya Amini, Steven H. Lin, Caimiao Wei, Pamela K. Allen, James D. Cox, Ritsuko Komaki
Published 2012Artigo -
3
-
4
Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database by Samantha M. Buszek, Karine A. Al Feghali, Hesham Elhalawani, Neil Chevli, Pamela K. Allen, Caroline Chung
Published 2020Artigo -
5
-
6
-
7
-
8
-
9
Phase 2 study of high‐dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer by Joe Y. Chang, Ritsuko Komaki, Charles Lu, Hong Wen, Pamela K. Allen, Anne S. Tsao, Michael T. Gillin, Radhe Mohan, James D. Cox
Published 2011Artigo -
10
-
11
-
12
-
13
-
14
Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma by Daniel R. Gomez, David S. Hong, Pamela K. Allen, James S. Welsh, Reza J. Mehran, Anne S. Tsao, Zhongxing Liao, Stephen Bilton, Ritsuko Komaki, David C. Rice
Published 2012Artigo -
15
Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease by Ferial Shihadeh, Valerie Reed, Stefan Faderl, L. Jeffrey Medeiros, Ali Mazloom, Mersiha Hadziahmetovic, Hagop M. Kantarjian, Pamela K. Allen, Leslie K. Ballas, Sherry Pierce, Bouthaina S. Dabaja
Published 2011Artigo -
16
Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases by Yun Oh, Sarah H. Taylor, B. Nebiyou Bekele, J. Matthew Debnam, Pamela K. Allen, Dima Suki, Raymond Sawaya, Ritsuko Komaki, David J. Stewart, Daniel D. Karp
Published 2009Artigo -
17
Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer by Ritsuko Komaki, Pamela K. Allen, Wei Xiong, George R. Blumenschein, Ximing Tang, J. Jack Lee, James W. Welsh, Ignacio I. Wistuba, Diane D. Liu, Waun Ki Hong
Published 2015Artigo -
18
Insurance Status and Racial Disparities in Cancer-Specific Mortality in the United States: A Population-Based Analysis by Hubert Y. Pan, Gary V. Walker, Stephen R. Grant, Pamela K. Allen, Jing Jiang, B. Ashleigh Guadagnolo, Benjamin D. Smith, Matthew Koshy, Chad G. Rusthoven, Usama Mahmood
Published 2017Artigo -
19
Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience by Shulian Wang, Zhongxing Liao, Chen Yuan, Joe Y. Chang, Melanda Jeter, Thomas Guerrero, Jaffer A. Ajani, Alexandria T. Phan, Stephen G. Swisher, Pamela K. Allen, James D. Cox, Ritsuko Komaki
Published 2006Artigo -
20
Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II–III inoperable non-small cell lung cancer by Quynh-Nhu Nguyen, N. Ly, Ritsuko Komaki, Lawrence B. Levy, Daniel R. Gomez, Joe Y. Chang, Pamela K. Allen, Reza J. Mehran, Charles Lu, Michael T. Gillin, Zhongxing Liao, James D. Cox
Published 2015Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Oncology
Radiation therapy
Cancer
Surgery
Biology
Lung cancer
Paleontology
Stage (stratigraphy)
Chemotherapy
Nuclear medicine
Radiology
Gastroenterology
Multivariate analysis
Proportional hazards model
Confidence interval
Lung
Radiosurgery
Toxicity
Univariate analysis
Cohort
Hazard ratio
Clinical trial
Metastasis
Pneumonitis
Proton therapy
Brain metastasis
Breast cancer
Carboplatin